RESUMEN
Infection is a leading cause of mortality and morbidity in the newborn and preterm neonates due to immuno-incompetence in these patients. Administration of intravenous immunoglobulin (IVIG) provides immunoglobulin G (IgG) that can protect the body from infection. In theory, morbidity and mortality due to infections in newborns and preterm infants could be reduced by the administration of IVIG. Two meta-analyses were evaluated comparing IVIG to treat various infection versus conventional treatments. The results showed that IVIG is not effective as an adjunctive treatment for suspected or proven infections in neonates.
La infección es la causa principal de la mortalidad y de la morbilidad entre los recién nacidos y los neonatos prematuros debido a la incompetencia inmunológica de estos pacientes. El suministro de inmunoglobulina por vía intravenosa brinda la inmunoglobulina G que protege al cuerpo humano de las infecciones. En términos teóricos, la morbilidad y la mortalidad por infecciones en recién nacidos y en bebés prematuros, podrían reducirse si se administra inmunoglobulina G intravenosa. Se evaluaron dos meta-análisis que comparaban el uso de la inmunoglobulina G intravenosa para tratar diversas infecciones con los tratamientos convencionales. Los resultados demostraron que dicha inmunoglobulina no es eficaz como tratamiento adyuvante para combatir sospechas de infección o infecciones comprobadas en los recién nacidos.
RESUMEN
OBJECTIVE: Large-scale comparison and comprehensive estimate on the access to health care and preventive services between Asian Americans/Pacific Islanders (AAPIs) and Non-Hispanic Whites (NHWs) has not been available. This study examines the racial disparities in access to health care and preventive services between AAPIs and NHWs in the USA. METHODS: Cross-sectional study of access to health care and preventive services among AAPIs compared to NHWs, using data from Behavioral Risk Factor Surveillance System 2005 to 2007 among 908,154 respondents aged > or = 18 years. RESULTS: The percentages of AAPIs (aged > or = 18 years) who reported having a personal healthcare provider, a Pap test (women aged > or =18), a fecal occult blood test (aged > or = 50) a sigmoidoscopy/colonoscopy (aged > or = 50), a PSA test (men aged > or = 40), blood cholesterol checked (aged > or =18 yrs), and pneumococcal vaccination (aged > or = 65 yrs) were 76.7%, 83.1%, 27.5%, 47.5%, 35.5%, 74.2%, and 51.2%, respectively. Compared to NHWs, AAPIs were significantly less likely to have a personal health care provider (adjusted odds ratio: 0.69 [95% confidence interval: 0.63-0.75]), a Pap test (0.18 [0.13-0.28]), a fecal occult blood test (0.50 [0.39-0.631), a sigmoidoscopy/colonoscopy (0.64 [0.50-0.81]), a PSA test (0.35 [0.26-0.47]), blood cholesterol checked (0.71 [0.64-0.80]), and pneumococcal vaccination (0.52 [0.42-0.65]). CONCLUSION: This study suggests that disparities exist between AAPIs and NHWs in 1 of 4 selected health care access indicators and 6 of 8 selected preventive services.